Vimarsana
Biggest News Aggregation in the World

Page 16 - Beigene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Today - Breaking & Trending Today

BGNE INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation – BGNE - Vimarsana News

BGNE INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation – BGNE

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of BeiGene, Ltd. resulting from allegations that BeiGene... | June 15, 2023

BeiGene, Ltd. (NASDAQ:BGNE) COO Sells $739,586.43 in Stock - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) COO Sells $739,586.43 in Stock

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) COO Xiaobin Wu sold 3,291 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $224.73, for a total transaction of $739,586.43. The sale was disclosed in a legal filing with the SEC, which can be […]

BeiGene, Ltd. (NASDAQ:BGNE) Given Consensus Rating of "Moderate Buy" by Brokerages - Vimarsana News

BeiGene, Ltd. (NASDAQ:BGNE) Given Consensus Rating of "Moderate Buy" by Brokerages

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) has received an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among brokerages that […]

Source: wkrb13.com
BeiGene (NASDAQ:BGNE) Trading Down 3.1% - Vimarsana News

BeiGene (NASDAQ:BGNE) Trading Down 3.1%

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating)’s stock price traded down 3.1% on Tuesday . The stock traded as low as $212.34 and last traded at $215.03. 16,488 shares were traded during mid-day trading, a decline of 92% from the average session volume of 212,068 shares. The stock had previously closed at $221.84. Analyst Ratings Changes […]

BeiGene, Ltd.: BRUKINSA Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia - Vimarsana News

BeiGene, Ltd.: BRUKINSA Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia

BeiGene's BTKi is approved in more than 65 markets globally BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, announced today that BRUKINSA (zanubrutinib), a